文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

医院价值导向购买项目与医院质量变化的关系

Changes in Hospital Quality Associated with Hospital Value-Based Purchasing.
PubMed 文献 · N Engl J Med · 2017-01-01
一句话结论HVBP项目未显著改善临床过程或患者体验,仅与肺炎患者30天死亡率降低相关,对急性心肌梗死和心力衰竭死亡率无显著影响。

该研究评估了2013财年起实施的医院价值导向购买(HVBP)项目对急性护理医院质量的影响。研究比较了暴露于HVBP的急性护理医院与未暴露的对照医院(关键接入医院),匹配基于干预前质量表现,评估了HVBP前4年的表现。结果显示,临床过程和患者体验的改善在暴露组与对照组间无显著差异,差中差估计分别为0.079 SD(95%CI -0.140至0.299)和-0.092 SD(95%CI -0.307至0.122)。HVBP与急性心肌梗死(-0.282个百分点,95%CI -1.715至1.152)和心力衰竭(-0.212个百分点,95%CI -0.532至0.108)死亡率降低无显著关联,但与肺炎死亡率显著降低相关(-0.431个百分点,95%CI -0.714至-0.148)。

要点

  • HVBP项目未显著改善临床过程 measures(差中差0.079 SD,95%CI -0.140至0.299)或患者体验(-0.092 SD,95%CI -0.307至0.122)。
  • HVBP与急性心肌梗死患者30天死亡率降低无显著关联(差中差-0.282个百分点,95%CI -1.715至1.152)。
  • HVBP与心力衰竭患者30天死亡率降低无显著关联(差中差-0.212个百分点,95%CI -0.532至0.108)。
  • HVBP与肺炎患者30天死亡率显著降低相关(差中差-0.431个百分点,95%CI -0.714至-0.148)。
  • 结论:HVBP未与临床过程或患者体验改善相关,且三个死亡率指标中有两个无显著降低。

适用人群与场景

  • 急性护理医院(暴露于HVBP)与关键接入医院(未暴露于HVBP,作为对照)的匹配样本。
  • 匹配基于干预前质量指标表现。
  • 分析样本医院数量范围:急性心肌梗死死亡率分析1364家,肺炎死亡率分析2615家;对照医院数量范围31至617家。

研究设计与关键结果

  • 研究设计:评估HVBP项目实施后质量变化的研究,比较暴露于HVBP的急性护理医院与未暴露的对照医院(关键接入医院),匹配基于干预前质量表现。
  • 主要终点:临床过程综合测量和患者体验综合测量(以标准差为单位,1表示高于医院均值1个标准差),以及急性心肌梗死、心力衰竭、肺炎患者的30天风险标准化死亡率。
  • 临床过程改善:暴露于HVBP的医院与对照医院间无显著差异,差中差估计0.079 SD(95%CI -0.140至0.299)。
  • 患者体验改善:暴露于HVBP的医院与对照医院间无显著差异,差中差估计-0.092 SD(95%CI -0.307至0.122)。
  • 急性心肌梗死死亡率:HVBP与无显著降低相关,差中差估计-0.282个百分点(95%CI -1.715至1.152)。
  • 心力衰竭死亡率:HVBP与无显著降低相关,差中差估计-0.212个百分点(95%CI -0.532至0.108)。
  • 肺炎死亡率:HVBP与显著降低相关,差中差估计-0.431个百分点(95%CI -0.714至-0.148)。
  • 评估时间:HVBP实施后前4年。

证据类型、等级与局限

  • 证据类型:研究论文(基于医院数据的比较效果分析)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。
  • 研究结论:HVBP与临床过程或患者体验改善无显著关联,且与三个死亡率指标中两个的无显著降低相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Starting in fiscal year 2013, the Hospital Value-Based Purchasing (HVBP) program introduced quality performance-based adjustments of up to 1% to Medicare reimbursements for acute care hospitals.

METHODS: We evaluated whether quality improved more in acute care hospitals that were exposed to HVBP than in control hospitals (Critical Access Hospitals, which were not exposed to HVBP). The measures of quality were composite measures of clinical process and patient experience (measured in units of standard deviations, with a value of 1 indicating performance that was 1 standard deviation [SD] above the hospital mean) and 30-day risk-standardized mortality among patients who were admitted to the hospital for acute myocardial infarction, heart failure, or pneumonia. The changes in quality measures after the introduction of HVBP were assessed for matched samples of acute care hospitals (the number of hospitals included in the analyses ranged from 1364 for mortality among patients admitted for acute myocardial infarction to 2615 for mortality among patients admitted for pneumonia) and control hospitals (number of hospitals ranged from 31 to 617). Matching was based on preintervention performance with regard to the quality measures. We evaluated performance over the first 4 years of HVBP.

RESULTS: Improvements in clinical-process and patient-experience measures were not significantly greater among hospitals exposed to HVBP than among control hospitals, with difference-in-differences estimates of 0.079 SD (95% confidence interval [CI], -0.140 to 0.299) for clinical process and -0.092 SD (95% CI, -0.307 to 0.122) for patient experience. HVBP was not associated with significant reductions in mortality among patients who were admitted for acute myocardial infarction (difference-in-differences estimate, -0.282 percentage points [95% CI, -1.715 to 1.152]) or heart failure (-0.212 percentage points [95% CI, -0.532 to 0.108]), but it was associated with a significant reduction in mortality among patients who were admitted for pneumonia (-0.431 percentage points [95% CI, -0.714 to -0.148]).

CONCLUSIONS: In our study, HVBP was not associated with improvements in measures of clinical process or patient experience and was not associated with significant reductions in two of three mortality measures. (Funded by the National Institute on Aging.).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Ryan AM, Krinsky S, Maurer KA, et al. Changes in Hospital Quality Associated with Hospital Value-Based Purchasing. N Engl J Med. 2017. PMID: 28614675. doi:10.1056/NEJMsa1613412

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。